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Multiple epiphyseal dysplasia (MED) is an autosomal dominant skeletal disorder 
characterized by early onset osteoarthritis with short stature and stubby fingers. 
Linkage analyses have identified at least three genetic loci for MED: EDM1 on chro­
mosome 19,1 EDM2 on chromosome l ,2 and an additional locus.3 EDM1 is caused 
by mutations in the cartilage oligomeric matrix protein gene (COMP);4 mutations in 
COMP have also been demonstrated in pseudoachondroplasia (PSACH).5 We exam­
ined a large Dutch family with MED and found that the disorders in this family is 
caused by a mutation in the a2(IX) collagen gene,6 The characteristic clinical fea­
tures of affected individuals include pain in the knee joints and waddling gait be­
tween 3 and 6 years of age. X rays of knee joints showed the typical changes of mul­
tiple epiphyseal dysplasia: flattened, irregular epiphyses, varus/valgus deformity of 
the knees, and gradually appearing osteoarthritis with or without loose bodies. Link­
age analysis with microsatellite markers from the EDM1 (D19S199, D19S212, 
D19S215, D19S222) and EDM2 (D1S186 and MYCL) regions showed significant 
linkage between the disease and EDM2.
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Figure 1. Diagrams showing mutation in splice donor site and exon skipping leading to the in­
frame deletion in a2(IX) collagen in EDM2. Above the diagram showing the splice patterns of 
exons 2 , 3, and 4 in wild-type and mutant COL9A2, the nucleotide sequence o f the 3' region of 
exon 3 (uppercase letters) and the 5' end o f intron 3 {lowercase letters) is shown. The splice 
donor sequence g t  is gc  in the mutant. The result of cycle sequencing o f genomic DNA (anti­
sense strand) from an unaffected individual (lanes 1) and an affected individual (lanes 2) is 
shown in the upper, right-hand inset. The arrow indicates the step in the sequence ladder at 
which the affected individual is heterozygous for A and G. The result of RT-PCR amplification 
and acrylamide gel electrophoresis with RNA from an unaffected individual (lane 1) and an af­
fected individual (lane 2 ) is shown in the lower, right-hand inset. The bottom diagram shows 
the location of the 12 amino acid residue deletion in the COL3 domain o f  the a2(IX) collagen 
chain caused by the mutation.
To find the causative mutation we performed RT-PCR with total RNA from short­
term cultured chondrocytes, obtained during arthroscopic surgery, and from EBV 
transformed lymphoblasts from an affected patient. First-strand cDNAs were synthe­
sized with oligo(dT) primers using the Superscript Preamplification System (GIBCO 
BRL). Since the EDM2 locus includes COL9A2, PCR primers were designed to am­
plify the approximately 2-kb cDNA coding for a2(IX) collagen in four overlapping 
fragments. Second-round PCR had to be used to amplify overlapping cDNA frag­
ments encoding the NC2, COL2, NC3, and COL3 domains and the carboxyl half of 
the signal peptide of the ot2(IX) collagen chain with nested primers. When the PCR 
products were analyzed on 2% agarose gels all products were the same size from af­
fected and unaffected individuals except one containing coding sequences for the 
COL3 domain, This product migrated as a single band from unaffected individuals 
and as a double band from affected individuals. Dideoxy-nucleotide cycle sequenc-
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Figure 2. Diagram showing the potential fates of collagen IX trimers containing a mutated 
ot2(lX) chain. Within chondrocytes (grey ova!) mutated a2(IX) chains are likely to be incorpo­
rated into trimers. Such trimers would have a folding defect in the COL3 domain and may be 
degraded intracellularly, or be secreted and incorporated into fibrils, The abnormal conforma­
tion o f their COL3 domains may disrupt the normal function o f such molecules on the fibrillar 
surface.
ing (ampliCycle™, Perkin Elmer) showed a 36-nt deletion in the lower band. To bet­
ter analyze this deletion, second-round PCR was performed with more closely spaced 
primers; 0.5 |xL of [a-33P] dCTP (10 mM} 2000 Ci/m mol) were added to the reac­
tion (Fig. 1). Since the 36 nucleotide deletion corresponded to a single exon encod­
ing part of the amino terminal COL3 domain of the a2(IX) collagen polypeptide 
(Fig, 1), genomic DNA was PCR amplified for further analysis. Cycle sequencing of 
the genomic PCR products revealed that the sequence of the splice donor site of in- 
tron 3, GTGAG, was converted to GCGAG in one allele of the affected patient (F ig . 
1). This nucleotide change, A T-to-C transition, resulted in loss of an Hphl site in the 
genomic sequence of the affected allele. To test for cosegregation of this change with 
the disorder, we examined the loss of this restriction site in all family members by di­
gesting genomic PCR products with Hphl. All affected individuals were heterozy­
gous for this change, while all unaffected individuals were homozygous for the pres-
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ence of the HphI site (data not shown). We conclude, therefore, that the MED in this 
family is caused by a splice donor site mutation in intron 3 of the a2(IX) collagen 
gene, leading to exon skipping during RNA splicing and an in-frame loss of 12 
amino acid residues within a triple-helical domain of the polypeptide. The deletion 
may not have an effect on polypeptide synthesis or formation of collagen IX trimers; 
however, the mutation may have a dominant negative effect either at the level of pro­
tein secretion or supramolecular assembly (F ig. 2).
REFERENCES
1. O e h l m a n n ,  R #> G. P. S u m m e r v i l l e ,  G. Y e h ,  E. J. W e a v e r ,  S. A. Jim en ez  & R. G. K n o w l -
t o n .  1994. Genetic linkage mapping o f multiple epiphyseal dysplasia to the pericen- 
tromeric region o f chromosome 19, Am. J. Hum. Genet. 54: 3-10.
2. B r i g g s , M . D,, H. C h o i , M . W. W a r m a n , J. A .  L o u g h l i n , P. W o r d s w o r t h , B. C . S y k e s , C.
M. M. I r v e n ,  M. S m i t h ,  R .  W y n n e - D a v i e s ,  M . H .  L ip s o n ,  L . G . B i e s e c k e r ,  A. P. G a r ­
b e r ,  R .  L a c h m a n ,  B. R .  O l s e n ,  D. L. R im o in  & D. H. C o h n .  1994. Genetic mapping of a 
locus for multiple epiphyseal dysplasia (EDM2) to a region o f chromosome 1 containing 
a type IX collagen gene. Am, J. Hum. G e n e t .  55: 678-684.
3. D e e r e ,  M., S. H . B l a n t o n ,  C . I. S c o t t ,  L. O , L a n g e r ,  R .  M. P a u l i  & J. T. H e c h t .  1995. G e ­
netic heterogeneity in multiple epiphyseal dysplasia. Am. J. Hum. Genet. 56: 698-704.
4 . H e c h t , J., L. D. N e l s o n , E. C r o w d er ., Y. W a n g , F. B. E l d e r , W . R .  I-Ia r r is o n , C . A. F r a n -
c o m a n o ,  C. K. P r a n g e ,  G. G. L e n n o n ,  M. D e e r e  & J. L a w l e r .  1995. Mutations in exon 
1 7 B  of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nature 
Genet. 10: 325-329,
5. B r i g g s ,  M . D .t S. M , G. H o f f m a n ,  L. M . K in g , A. S. O l s e n ,  H .  M o h r e w e i s e r ,  J  G. L e ro y ,
G . R . M o r t i e r ,  D. L. R im o in ,  R. S. L a c h m a n ,  E, S. G a i n e s ,  J. A. C e k l e n i a k ,  R. G. 
K n o w l t o n  & D. H. C o h n .  1995. Pseudoachondroplasia and multiple epiphyseal dyspla­
sia due to mutations in the cartilage oligomeric matrix protein gene. Nature Genet. 10: 
330-336.
6 . M u r a g a k i ,  Y, E. C. M. M a r i m a n ,  S. E. C. v a n  B e e r s u m ,  M . P e r a l a ,  J. B, A. v a n  M o u r i k ,
M. L. W a rm a n , B. R. O l s e n  & B. C. J. H a m e l .  1996. A mutation in the gene encoding 
the oil chain o f the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal 
dysplasia (EDM2). Nature Genet. 12: 103-105.
